510(k) device
TheraVision Ultrasound Ablation System and ACOUSTx Applicators
Acoustic Medsystems, Inc. · System, Ablation, Ultrasound And Accessories (NTB, Class II) · First FDA decision Jan 13, 2016, newest Jan 13, 2016Tumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "TheraVision"
MAUDE reports
0
Brand "TheraVision", since 2015
PubMed studies
5
Mentioning "TheraVision"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TheraVision Ultrasound Ablation System and ACOUSTx Applicators
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K150019 · Decided Jan 13, 2016 · 373 days after receipt
Device type: System, Ablation, Ultrasound And Accessories (NTB) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TheraVision", any status and sponsor, newest update first.
Johnson & Johnson Vision Care, Inc.Not on our public-company list
NCT05530889 · 0 participants · Start Jan 15, 2024 · Primary completion May 13, 2024
Device: TEST Lens; CONTROL Lens · For: Ocular Physiology
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TheraVision", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NTB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TheraVision"[tiab]. The summary above synthesizes these.
- Sustained Delivery of Olopatadine from Vitamin-E Loaded Contact Lenses.
Reis IM, Dixon PJ, Sekar P, et al. · J Ocul Pharmacol Ther · 2024Research Support, N.I.H., Extramural
- Use of Ketotifen Fumarate-Eluting Daily Disposable Soft Contact Lens in Management of Ocular Allergy: Literature Review and Report of Two Cases.
Ono J, Toshida H · Cureus · 2022Case Reports
- A drug-eluting contact lens for allergic conjunctivitis.
Med Lett Drugs Ther · 2022
- A dexamethasone ophthalmic insert (Dextenza) for allergic conjunctivitis.
Med Lett Drugs Ther · 2023
- TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1.
Funk C, Uhlig N, Ruzsics Z, et al. · Mol Ther Oncol · 2024
Other devices of this type
Also filed under product code NTB.
- Sonatherm 600I Ultrasonic Lesion Generating SystemMisonix, Inc. · 510(k) 2008
- Ultrazonix Spine Minimal-Invasive Disc SystemUltrazonix Dnt AB · 510(k) 2006
- Misonix Inc. Sonatherm 600 Ultrasonic Lesion Generating SystemMisonix, Inc. · 510(k) 2006
- Ultracinch Ablation DeviceEpicor Medical, Inc. · 510(k) 2004
- Epicor Medical Ablation SystemEpicor Medical, Inc. · 510(k) 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.